Tech Company Financing Transactions
Pelvital Funding Round
Pelvital, based in Minneapolis, secured $2.3 million from Boomerang Ventures, Blue Pacific Ventures and Life Science Angels.
Transaction Overview
Company Name
Announced On
4/22/2024
Transaction Type
Venture Equity
Amount
$2,320,000
Round
Seed
Investors
Proceeds Purpose
The seed plus funding will be instrumental in expediting the commercialization of Flyte, Pelvital's novel FDA-cleared treatment for stress urinary incontinence (SUI) and weakened pelvic floor muscles.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
1000 Lasalle Avenue, SCH435
Minneapolis, MN 55403
USA
Minneapolis, MN 55403
USA
Phone
Website
Email Address
Overview
We are a women's health company on a mission to eliminate bladder leaks and improve pelvic floor health. We were founded by an international team of physicians and medical device professionals. Our vision is to significantly improve the lives of people who suffer from pelvic floor disorders through novel, easy-to-use products backed by strong clinical evidence. We are working to expand conservative treatment options that inspire women to treat conditions rather than cope with symptoms. We believe that women deserve safe, effective, clinically proven products to treat common problems like urinary incontinence.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lydia Zeller
Chief Financial Officer
Leota Pearson
Browse more venture capital transactions:
Prev: 4/22/2024: Lumeris venture capital transaction
Next: 4/22/2024: SNIPR Biome venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs